ES2054706T3 - Emulsion que contiene yodo. - Google Patents

Emulsion que contiene yodo.

Info

Publication number
ES2054706T3
ES2054706T3 ES87850192T ES87850192T ES2054706T3 ES 2054706 T3 ES2054706 T3 ES 2054706T3 ES 87850192 T ES87850192 T ES 87850192T ES 87850192 T ES87850192 T ES 87850192T ES 2054706 T3 ES2054706 T3 ES 2054706T3
Authority
ES
Spain
Prior art keywords
emulsion
stability
emulsion containing
containing iodine
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87850192T
Other languages
English (en)
Inventor
Karl Arvid Johannes P Wretlind
Bengt Magnus Ajaxon
Krassi Ivancev
Anders Lunderquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8198483&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2054706(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Application granted granted Critical
Publication of ES2054706T3 publication Critical patent/ES2054706T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UNA EMULSION PARA USO COMO AGENTE DE CONTRASTE DE RAYOS X Y QUE CONTIENE UNO O MAS LIPIDOS YODADOS EMULSIFICADOS ENUNA FASE ACUOSA. LA EMULSION CONTIENE UNO O MAS AMINOACIDOS, ACIDOS GRASOS O SUS SALES, VITAMINAS SOLUBLES EN GRASA Y/O UREA PARA AUMENTAR SU ESTABILIDAD. ADEMAS, LA EMULSION CONTIENE UNO O MAS ACEITES O GRASAS FARMACEUTICAMENTE ACEPTABLES. POR LOS AGENTES INCREMENTADORES DE LA ESTABILIDAD ES POSIBLE PREPARAR EMULSIONES DE LIPIDOS YODADOS QUE PUEDEN SER ESTERILIZADOS EN AUTOCLAVE Y SER ALMACENADOS DURANTE LARGO TIEMPO SIN ROMPER LA EMULSION.
ES87850192T 1987-06-11 1987-06-11 Emulsion que contiene yodo. Expired - Lifetime ES2054706T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87850192A EP0294534B2 (en) 1987-06-11 1987-06-11 Iodine containing emulsion

Publications (1)

Publication Number Publication Date
ES2054706T3 true ES2054706T3 (es) 1994-08-16

Family

ID=8198483

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87850192T Expired - Lifetime ES2054706T3 (es) 1987-06-11 1987-06-11 Emulsion que contiene yodo.

Country Status (10)

Country Link
US (1) US4917880A (es)
EP (1) EP0294534B2 (es)
JP (1) JP2688605B2 (es)
AT (1) ATE89171T1 (es)
AU (1) AU612654B2 (es)
CA (1) CA1314478C (es)
DE (1) DE3785849T2 (es)
ES (1) ES2054706T3 (es)
FI (1) FI98047C (es)
NO (1) NO176747C (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2694342B2 (ja) * 1988-02-22 1997-12-24 日本シエーリング株式会社 Ｃｔスキャン用造影剤
US5377681A (en) * 1989-11-13 1995-01-03 University Of Florida Method of diagnosing impaired blood flow
DE4111939A1 (de) * 1991-04-12 1992-10-22 Fresenius Ag Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels
SE470086B (sv) * 1991-04-23 1993-11-08 Kabi Pharmacia Ab Organspecifik emulsion
IT1247946B (it) * 1991-05-17 1995-01-05 Instrumentation Lab Srl Stabilizzazione in forma liquida dell'enzima urato ossidasi
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
CN1531399A (zh) * 2001-05-14 2004-09-22 瓦西里・彼得罗维奇・安德烈丘克 预防碘缺乏和优化碘代谢的生物活性食品添加剂和生物活性饲料添加剂,以及含该添加剂的食品和饲料
US20050079131A1 (en) * 2003-08-08 2005-04-14 Lanza Gregory M. Emulsion particles for imaging and therapy and methods of use thereof
US20140065067A1 (en) * 2010-12-17 2014-03-06 Universite De Strasbourg Radiopaque iodinated products intended for use medical imaging and their methods
RU2448732C1 (ru) * 2011-04-05 2012-04-27 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГУ "РНЦРХТ" Минздравсоцразвития России) Рентгеноконтрастное средство
EP2719398B1 (en) * 2011-06-13 2016-01-20 National University Corporation Chiba University Medical tissue-marker and manufacturing method for same
FR3039767B1 (fr) 2015-08-04 2017-09-08 Guerbet Sa Composition destinee a vectoriser un agent anticancereux
EA202090139A1 (ru) 2017-08-07 2020-08-06 Юниверсити Оф Женева Контрастный агент для компьютерной томографии
CN112493426A (zh) * 2019-09-16 2021-03-16 东北农业大学 一种适合7-12月龄婴儿的蔬菜三文鱼泥罐头及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE505429A (es) *
GB676738A (en) * 1949-11-16 1952-07-30 Bayer Ag Parenterally administrable x-ray contrast agents
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium
FR5986M (es) * 1966-11-22 1968-06-21
US4404182A (en) * 1980-01-08 1983-09-13 The United States Of America As Represented By The Department Of Health And Human Services Ethiodized oil emulsion for intravenous hepatography
JPS5832829A (ja) * 1981-08-22 1983-02-25 Green Cross Corp:The 血管造影剤
JPS58110522A (ja) * 1981-12-25 1983-07-01 Green Cross Corp:The 血管造影剤
JPS60166626A (ja) * 1984-02-09 1985-08-29 Green Cross Corp:The 血管造影剤

Also Published As

Publication number Publication date
EP0294534B2 (en) 2001-04-11
EP0294534A1 (en) 1988-12-14
DE3785849D1 (de) 1993-06-17
JP2688605B2 (ja) 1997-12-10
JPS6456623A (en) 1989-03-03
AU612654B2 (en) 1991-07-18
ATE89171T1 (de) 1993-05-15
FI98047B (fi) 1996-12-31
AU1756488A (en) 1989-01-12
US4917880A (en) 1990-04-17
NO882579D0 (no) 1988-06-10
CA1314478C (en) 1993-03-16
DE3785849T2 (de) 1993-08-26
NO176747C (no) 1995-05-24
FI882738A (fi) 1988-12-12
NO176747B (no) 1995-02-13
FI98047C (fi) 1997-04-10
NO882579L (no) 1988-12-12
FI882738A0 (fi) 1988-06-09
EP0294534B1 (en) 1993-05-12

Similar Documents

Publication Publication Date Title
ES2054706T3 (es) Emulsion que contiene yodo.
CA1333570C (en) Topically applicable preparations for treatment of presbyderma
MX172826B (es) Emulsiones acuosas de fluorocarburos estables
DK0759773T3 (da) Tårekirtelspecifikke emulsioner til topisk påføring på okulært væv
CO4130180A1 (es) Composiciones para el cuidado de la piel que contienen una emulsion de agua en aceite y un retinoide
MX192671B (es) Composiciones para el cuidado de la piel que contienen imidazoles.
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
ATE141780T1 (de) Öl in wasser emulsionen verwendbar für die herstellung von einer creme
MX166589B (es) Composicion anti-inflamatoria, humedecedora de la piel y metodo para prepararla
DK0624363T3 (da) Lipidsammensætning til kosmetiske produkter indeholdende triglycerider af umættede, fede syrer
BR0015939A (pt) Sistemas terapêuticos transdérmicos com estabilidade aperfeiçoada e um processo para a sua preparação
BR9406228A (pt) Agente de contraste de ultra-som e processos para a preparação do mesmo e para a geração de imagens melhoradas de um corpo de animal humano ou n o-humano
DE68917678T2 (de) Verfahren und Mittel zur Behandlung der Alzheimer-Krankheit, verwandter Demenzen und Epilepsie.
KR970705988A (ko) 연골 조직의 이상에 기인하는 질환의 예방 또는 치료제(Preventive or remedy for diseases caused by abnormalities in cartilage tissues)
MX172808B (es) Trigliceridos que contienen acidos grasos saturados que tienen de 20 a 24 atomos de carbono utiles para disminuir los niveles de colesterol en la sangre
ATE69550T1 (de) Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
CO4930309A1 (es) Emulsiones tipo aceite en agua que contienen cantidades suficientes de un agente emulsificante de agua en aceite para disminuir tiempo de absorcion por frotamiento
MX172107B (es) Procedimiento para la desinfeccion de masas para vaciado medicinales
PT92228A (pt) Processo para a preparacao de uma formulacao oral liquida, contendo diclofenac
SE8705064L (sv) Emulsion foer parenteral administrering
KR920703047A (ko) 트리글리세라이드를 함유하는 포도필로톡신 제제
AR015615A1 (es) Una crema para la piel con componentes humectantes y absorbentes
KR970061084A (ko) 닭의 발육을 촉진하는 방법
DK138191D0 (da) Salicylsyreholdigt middel til behandling af afskallende hudlidelser
MX9304788A (es) Compuesto de 1, 2, 3, 4-oxatriazol-5-imina 3- y 5-sustituidos, procedimiento para su preparacion y composiciones farmaceticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 294534

Country of ref document: ES